Les causes chimiques des diverses épidémies de sida








télécharger 0.52 Mb.
titreLes causes chimiques des diverses épidémies de sida
page10/10
date de publication31.03.2017
taille0.52 Mb.
typeDocumentos
b.21-bal.com > droit > Documentos
1   2   3   4   5   6   7   8   9   10
311 156–158

Quinn T C, Mann J M, Curran J W and Piot P 1986 AIDS in Africa: an epidemiological paradigm; Science 234 955–963

Quinn T C, Piot P, McCormick J B, Feinsod F M, Taelman H, Kapita B, Stevens W and Fauci A S 1987 Serologic and immunologic studies in patients with AIDS in North America and Africa: the potential role of infectious agents as cofactors in human immunodeficiency virus infection; Jama 257 2617–2621

Race E M, Adelson-Mitty J, Kriegel G R, Barlam T F, Reimann K A, Letvin N L and Japour A J 1998 Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease; Lancet 351 252–255

Rappoport J 1988 AIDS INC (San Bruno, CA: Human Energy Press)

Rasnick D 1997 Kinetics analysis of consecutive HIV proteolytic cleavages of the Gag-Pol polyprotein; J. Biol. Chem. 272 6348–6353

Richman D D, Fischl M A, Grieco M H, Gottlieb M S, Volberding P A, Laskin O L, Leedom J M, Groopman J E, Mildvan D, Hirsch M S, Jackson G G, Durack D T, Nusinoff-Lehrman S and the AZT Collaborative Working Group 1987 The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex; N. Engl. J. Med. 317 192–197

Robert Koch Institut 2000 HIV/AIDS-Halbjahresbericht I/2000; Epidemiol. Bulletin 15 September, pp 1–16

Rogers M F, Ou C-Y, Rayfield M, Thomas P A, Schoenbaum E E, Abrams E, Krasinski K, Selwyn P A, Moore J, Kaul A, Grimm K T, Bamji M, Schochetman G and the New York City Collaborative Study of Maternal HIV Transmission and Montefiori Medical Center HIV Perinatal Transmission Study Group 1989 Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers; N. Engl. J. Med. 320 1649–1654

Root-Bernstein R 1993 Rethinking AIDS; The tragic cost of premature consensus (New York: Free Press)

Rosenberg M J and Weiner J M 1988 Prostitutes and AIDS: A health department priority?; Am. J. Public Health 78 418–423

Ross E 2003 Sub-Saharan Africa, Kenya and the Malthusian paradigm in contemporary development thinking; in Reclaiming knowledge for diversity (ed.) M Pimbert (Earthscan) (in press)

Russell S 2001 Deceptive AIDS ads must stop, FDA says; San Francisco Chronicle, 28 April, p. A1, A13

Sabin C A, Phillips A N and Lee C A 1996 Response: arguments contradict the “foreign protein-zidovudine” hypothesis; Br. Med. J. 312 211–212

Sadownick D 1994 Kneeling at the Crystal Cathedral; Genre December/January, pp 40–45, 86–90

Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Koster A, Hess B, Evers M, von Figura K et al 1995 Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells; EMBO J. 14 3599–3608

Sande M A 1986 Transmission of AIDS. The case against casual contagion; N. Engl. J. Med. 314 380–382

Saves M, Vandentorren S, Daucourt V, Marimoutou C, Dupon M, Couzigou P, Bernard N, Mercie P and Dabis F 1999 Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996–1998. Groupe dEpidemiologie Clinique de Sida en Aquitaine (GECSA); Aids 13 F115–121

Scalfaro P, Chesaux J J, Buchwalder P A, Biollaz J and Micheli J L 1998 Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment; Intensive Care Med. 24 247–250

Schechter M T, Craib K J P, Gelmon K A, Montaner J S G, Le T N and O’Shaughnessy M V 1993 HIV-1 and the aetiologyof AIDS; Lancet 341 658–659

Schnittman S M, Psallidopoulos M C, Lane H C, Thompson L, Baseler M, Massari F, Fox C H, Salzman N P and Fauci A 1989 The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4; Science 245 305–308

Seligmann M, Chess L, Fahey J L, Fauci A S, Lachmann P J, L’Age-Stehr J, Ngu J, Pinching A J, Rosen F S, Spira T J and Wybran J 1984 AIDS–an immunologic reevaluation; N. Engl. J. Med. 311 1286–1292

Seligmann M, Warrell D A, Aboulker J-P, Carbon C, Darbyshire J H, Dormont J, Eschwege E, Girling D J, James D R, Levy J-P, Peto P T A, Schwarz D, Stone A B, Weller I V D, Withnall R, Gelmon K, Lafon E, Swart A M, Aber V R, Babiker A G, Lhoro S, Nunn A J and Vray M 1994 Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIVinfection; Lancet 343 871–881

Selik R M, Starcher E T and Curran J W 1987 Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends; Aids 1 175–182

Shenton J 1998 Positively False: exposing the myths around HIV and AIDS (London/New York: IB Tauris)

Shilts R 1987 And the band played on (New York: St. Martin’s Press)

Simmonds P, Balfe P, Peutherer J F, Ludlam C A, Bishop J O and Leigh-Brown A J 1990 Human immunodeficiency virus infected

individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers; J. Virol. 64 864–872

Smothers K 1991 Pharmacology and toxicology of AIDS therapies; AIDS Reader 1 29–35

Stedman's Medical Dictionary 1982 (Baltimore: Wiliams & Wilkins)

Stewart G T, Mhlongo S, de Harven E, Fiala C, Koehnlein C, Herxheimer A, Duesberg P, Rasnick D, Giraldo R, Kothari M, Bialy H and Geshekter C 2000 The Durban Declaration is not accepted by all; Nature (London) 407 286

Stolberg S 2001 In AIDS war, new weapons and new victims; New York Times, June 3, p. 1

Stoneburner R L, Des Jarlais D C, Benezra D, Gorelkin L, Sotheran J L, Friedman S R, Schultz S, Marmor M, Mildvan D and Maslansky R 1988 A larger spectrum of severe HIV-Irelated disease in intravenous drug users in New York City; Science 242 916–919

Szasz T 2001 The Therapeutic State: The Tyranny of Pharmacracy; The Independent Review, Spring, pp 485–501

Tanaka M 1996 Abrams cautious on use of new AIDS drugs; Synapse (University of California San Francisco) October 10, p. 1, 5

The Durban Declaration 2000 The Durban Declaration; Nature (London) 406 15–16

Thompson M B, Dunnick J K, Sutphin M E, Giles H D, Irwin R D and Prejean J D 1991 Hematologic toxicity of AZT and ddC administered as single agents and in combination to rats and mice; Fundamental Appl. Toxicol. 17 159–176

Till M and MacDonnell K B 1990 Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?; Ann. Int. Med. 113 492–494

Toltzis P, Mourton T and Magnuson T 1993 Effect of zidovudine on preimplantation murine embryos; Antimicrob. Agents Chemother. 37 1610–1613

Toufexis A 1991 Innocent victims; Time May 13, pp 56–60 US Bureau of the Census International Data Base 2001 World population by region and development category: 1950–2025 (US Department of Commerce, Bureau of the Census)

Van de Perre P, Rouvroy D, Lepage P, Bogaerts J, Kestelyn P, Kayihigi J, Hekker A C, Butzler J P and Clumeck N 1984 Acquired immunodeficiency syndrome in Rwanda; Lancet 2 62–65

Veugelers P J, Page K A, Tindall B, Schechter M T, Moss A R, Winkelstein W W, Cooper D A, Craib K J P, Charlebois E, Coutinho R A and Van Griensven G J P 1994 Determinants of HIV disease progression among homsexual men registered in the tricontinental seroconverter study; Am. J. Epidemiol. 140 747–758

Volberding P A, Lagakos S W, Koch M A, Pettinelli C, Myers M W, Booth D K, Balfour H H Jr, Reichman R C, Bartlett J A, Hirsch M S, Murphy R L, Hardy W D, Soeiro R, Fischl M A, Bartlett J G, Merigan T C, Hyslop N E, Richman D D, Valentine F T, Corey L and the AIDS Clinical Trial Group of the National Insitute of Allergy and Infectious Disease 1990 Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter; N. Engl. J. Med. 322 941–949

Ward J W, Bush T J, Perkins H A, Lieb L E, Allen J R, Goldfinger D, Samson S M, Pepkowitz S H, Fernando L P, Holland P V, Kleinman S H, Grindon A J, Garner J L, Rutherford G W and Holmberg S D 1989 The natural history of trasfusion-associated infection with human immunodeficiency virus; N. Engl. J. Med. 321 947–952

Wei X, Ghosh S K, Taylor M E, Johnson V A, Emini E A, Deutsch P, Lifson J D, Bonhoeffer S, Nowak M A, Hahn B H, Saag M S and Shaw G M 1995 Viral dynamics in human immunodeficiency virus type 1 infection; Nature (London) 373 117–122

Weiss R 1991 Provenance of HIV strains; Nature (London) 349 374

Weiss R and Jaffe H 1990 Duesberg HIV and AIDS; Nature (London) 345 659–660

White House Office of National Drug Control Policy 1998 Fact Sheet: Drug data summary (DHSS, The White House)

Woody G E, VanEtten-Lee M L, McKirnan D, Donnell D, Metzger D, Seage G III and Gross M 2001 Substance use among men who have sex with men: comparison with a national household survey; J. Acquir. Immune Defic. Syndr. 27 86–90

World Health Organization 1986 Provisional WHO clinical case definition for AIDS; Weekly Epidemiological Records, March 7, 10 72–73

World Health Organization 1999 Global AIDS surveillance, Part II; Weekly Epidemiological Records 74 (3 December) 409–411

World Health Organization 2000 Global AIDS surveillance, Part I; Weekly Epidemiological Records 75 (26 November) 379–383

World Health Organization 2001a Global AIDS surveillance, Part II; Weekly Epidemiological Records 76 (50) 390–396

World Health Organization 2001b Global situation of the HIV/AIDS pandemic, end 2001 Part I; Weekly EpidemiologicalRecords 76 (49) 381–384

Zhang L, Yu W, He T, Yu J, Caffrey R E, Dalmasso E A, Fu S, Pham T, Mei J, Ho J J, Zhang W, Lopez P and Ho D D 2002 Contribution of Human {alpha}-Defensin-1, -2 and -3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor; Science 298 995–2000

Zuger A 2001 A molecular offspring, off to join the AIDS wars; New York Times, 20 March, p. D7
Traduction d'Yves de St. Vaulry. Avec l'autorisation du Journal Bioscience et les auteurs.

1   2   3   4   5   6   7   8   9   10

similaire:

Les causes chimiques des diverses épidémies de sida iconLa médecine indique que le sida, ayant officiellement causé 28 millions...
Nécessité d’organiser des "fléaux" contre la population noire. En 1931, des tests sont faits secrètement sur les Afro-Américains...

Les causes chimiques des diverses épidémies de sida iconSynthèses chimiques moins nocives
«chimie verte» («green chemistry») a été développé aux États-Unis au début des années 1990 dans le but d'offrir un cadre à la prévention...

Les causes chimiques des diverses épidémies de sida iconI. le sida, les virus concernes, leur pathogenie

Les causes chimiques des diverses épidémies de sida icon1. 2 Classification selon Delay et Deniker, 1957
«designer drugs» ou les drogues de bricolage, substances synthétisé artificiellement dans des laboratoires clandestins à partir des...

Les causes chimiques des diverses épidémies de sida iconProgramme Commun des Nations Unies sur le vih/sida

Les causes chimiques des diverses épidémies de sida iconEditions Christian Pirot
«Bibliothèque de la Pléiade» en douze volumes (CH), ainsi que les deux volumes parus des Œuvres diverses (OD)

Les causes chimiques des diverses épidémies de sida iconLes liaisons chimiques et les interactions moléculaires
Liaisons hydrogènes car ils sont les plus petits et possèdent une fort concentration de charges

Les causes chimiques des diverses épidémies de sida iconPour mieux comprendre le jargon des biologistes… Bio-fiches
«organismes différents vivant ensemble». Cette définition englobe les diverses relations classiquement qualifiées de phorésie, de...

Les causes chimiques des diverses épidémies de sida iconSe propose d’étudier l’intervention du facteur «temps» dans les transformations chimiques

Les causes chimiques des diverses épidémies de sida iconRecherche d'un criterium. Examen des diverses théories transformistes...








Tous droits réservés. Copyright © 2016
contacts
b.21-bal.com